4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000109
Chief Legal Officer sold 1,707 shares at $28.36 ($48,411)
- Chief Legal Officer acquired 5,750 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Burns James William Chief Legal Officer | 2023-06-28 | Option exercise 10b5-1 | +5,750 | 31,992 | D: show line 1 in the form | ||
| Burns James William Chief Legal Officer | 2023-06-30 | Sale 10b5-1 | −1,707 | $28.36 | $48,411 | 30,285 | D: show line 2 in the form |
| Open-market sales · 1,707 sh · avg $28.36 · $48,411 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Burns James William Chief Legal Officer | 2023-06-28 | Option exercise · Performance share units 10b5-1 | −5,750 | 5,750 | D: show line 3 in the form |
Loading xslF345X04/wk-form4_1688155746.xml…